|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | ||||||||||
| Restricted cash | ||||||||||
| Short-term investments | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| ROU assets - operating leases | ||||||||||
| Property and equipment, net | ||||||||||
| Deferred offering costs | ||||||||||
| Other Assets Noncurrent | ||||||||||
| Total assets | ||||||||||
| Liabilities, convertible preferred stock, and stockholders' (deficit) | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued and other current liabilities | ||||||||||
| Current portion of operating lease liabilities | ||||||||||
| Deferred revenue | ||||||||||
| Total current liabilities | ||||||||||
| Lease liabilities, net of current portion | ||||||||||
| Long-term convertible promissory note | ||||||||||
| Embedded derivative liability | ||||||||||
| Other noncurrent liabilities | ||||||||||
| Total liabilities | ||||||||||
| Convertible preferred stock, $0.0001 par value; no shares authorized at September 30, 2021 and 54,039,749 shares authorized at December 31, 2020; no shares issued and outstanding at September 30, 2021 and 32,198,879 shares issued and outstanding at December 31, 2020; $0 and $30,007 aggregate liquidation preference at September 30, 2021 and December 31, 2020, respectively | ||||||||||
| Stockholders' equity | ||||||||||
| Preferred stock, $0.0001 par value; 50,000,000 and no shares authorized at September 30, 2021 and December 31, 2020, respectively; no shares issued and outstanding at September 30, 2021 and December 31, 2020 | ||||||||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized at September 30, 2023 and December 31, 2022; 50,088,633 and 41,177,706 shares issued as of September 30, 2023 and December 31, 2022, respectively; 50,088,633 and 41,095,564 shares outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...
